Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs

BACKGROUND: Successful introduction of new anticancer agents into the clinic is often hampered by a lack of qualified biomarkers. Studies have been conducted of 17 ELISAs representing a potential panel of pharmacodynamic/predictive biomarkers for drugs targeted to tumour vasculature. METHODS: The fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Brookes, K, Cummings, J, Backen, A, Greystoke, A, Ward, T, Jayson, G C, Dive, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869162/
https://www.ncbi.nlm.nih.gov/pubmed/20407440
http://dx.doi.org/10.1038/sj.bjc.6605661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869162/
https://www.ncbi.nlm.nih.gov/pubmed/20407440
http://dx.doi.org/10.1038/sj.bjc.6605661

Ejemplares similares